Ascorbate synthesis-dependent glutathione consumption in mouse liver  by Bánhegyi, Gábor et al.
FEBS 16691 FEBS Letters 381 (1996) 3941 
Ascorbate synthesis-dependent glutathione consumption in mouse liver 
Gfibor Bfinhegyi, Mikl6s Csala, Lfiszl6 Braun, Tam/ts Garz6, J6zsef Mandl* 
1st Institute of Biochemistry, Semmelweis Medical University, PO Box 260, 1444 Budapest, Hungary 
Received 16 January 1996 
Abstract Ascorbate synthesis causes glutathione consumption 
in the liver. Addition of gulonolactone resulted in an increase of 
ascorbate production in isolated murine hepatocytes. At the same 
time, a decrease in reduced glutathione (GSH) level was 
observed. In hepatic microsomal membranes, ascorbate synthesis 
stimulated by gulonolactone caused an almost equimolar 
consumption of GSH. This effect could be counteracted by the 
addition of catalase or mercaptosuccinate, indicating the role of 
hydrogen peroxide formed during ascorbate synthesis in the 
depletion of GSH. The observed phenomenon may be one of the 
reasons why the evolutionary loss of ascorbate synthesis could be 
advantageous. 
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amino acids (1 mM of each) under constant bubbling of gas (02/ 
CO2, 95 : 5, v/v) at 37°C. Incubations were terminated by the addition 
of TCA (5% final concentration). 
2.3. Microsomal experiments 
Hepatic microsomal membranes were prepared and stored accord- 
ing to [6]. Microsomes (usually 1 mg protein/ml) were incubated in 50 
mM potassium phosphate buffer pH 7.4 containing 5 mM MgC12 at 
37°C for 30 min. Incubations were terminated by the addition of TCA 
(5% final concentration). 
2.4. Metabolite measurements 
Ascorbate and GSH were measured in the trichloroacetic acid so- 
luble supernatant of the cells or microsomes by the method of Omaye 
[7,8] and Ball [9], respectively. Microsomal oxygen consumption was 
detected polarographically at 37°C using a Clarke-type oxygen elec- 
trode. Microsomal hydrogen peroxide production was measured en- 
zimatically according to [10] in the incubation medium mentioned 
above supplemented with 40 ~tg/ml horseradish peroxidase, 66 ~tg/ml 
o-dianisidine and 0.2 mM sodium azide. 
1. Introduction 
Ascorbic acid and glutathione are involved in the antioxi- 
dant defense of the cell. Their connections and interactions 
have been described from several aspects: they can substitute 
each other [1], dehydroascorbate can be reduced at the ex- 
pense of GSH [2] and glutathione depletion results in the 
stimulation of ascorbate synthesis [3]. In ascorbate-synthesis- 
ing animals, the formation of ascorbate from gulonolactone 
catalysed by microsomal gulonolactone oxidase is accompa- 
nied by the stoichiometric consumption of 02 and production 
of the oxidant hydrogen peroxide [4]. Metabolism of hydrogen 
peroxide by glutathione peroxidase requires reduced glu- 
tathione. Therefore, we supposed that synthesis of ascorbate 
should decrease the intracellular glutathione level. To prove 
our hypothesis, experiments were undertaken to investigate 
the effect of ascorbate synthesis stimulated by the addition 
of gulonolactone on the oxidation of GSH in isolated mouse 
hepatocytes and liver microsomal membranes. 
2. Experimental 
2.1. Materials 
Collagenase (type IV), ot,og-dipyridyl, Ellman's reagent, glyoxylic 
acid, 3-amino-l,2,4-triazole (aminotriazole), mercaptosuccinic a id, 
o-dianisidine and catalase (EC 1.11.1.6) from bovine liver were bought 
from Sigma (St Louis, MO). Horseradish peroxidase (500 U/rag) was 
purchased from Reanal (Hungary). All other chemicals were of ana- 
lytical grade. 
2.2. Preparation and incubation of isolated mouse hepatocytes 
Isolated murine hepatocytes were prepared from male CFLP mice 
(30 35 g body weight; LATI, G6d6116, Hungary) by the collagenase 
perfusion method as detailed earlier [5]. Viability of the cells checked 
by the Trypan blue exclusion test was more than 90%. Cells (2x 106/ 
ml) were incubated in Krebs-Henseleit bicarbonate buffer containing 
2.5 mM Ca 2+, 1% albumin, 8.5 mM glucose, 5 mM pyruvate and 
*Corresponding author. Fax: (36) (1) 266 2615. 
2.5. Miscellaneous 
DNA content of isolated hepatocytes was measured by the method 
of Burton [11]. Protein contents were measured by the biuret method. 
Statistical analysis was performed using Student's t-test. 
3. Results 
The effect of ascorbate synthesis on reduced glutathione 
level was studied in mouse liver microsomal membranes. The 
activity of gulonolactone oxidase, an integral enzyme of hepa- 
tic endoplasmic reticulum, was stimulated by the addition of 
1 mM gulonolactone. The presence of gulonolactone, in agree- 
ment with previous observations [4], resulted in an increased 
oxygen consumption in microsomes (data not shown). Mea- 
surement of hydrogen peroxide in the presence of the catalase 
inhibitor azide showed a gulonolactone-dependent hydrogen 
peroxide formation; its rate (2.09 + 0.13 nmol/min/mg protein, 
n = 3) was similar to the rate of ascorbate synthesis (Table 1). 
In the presence of 1 mM glutathione, ascorbate production 
was accompanied by an almost equimolar GSH consumption 
(Table 1). In the absence of microsomes, gulonolactone did 
not decrease the GSH level of incubates (data not shown). 
The decrease in GSH was dependent on the initial GSH con- 
centration (Fig. la). GSH consumption was linear in time and 
was dependent on the protein content of incubates (data not 
shown). The time courses of GSH consumption and ascorbate 
synthesis howed parallel running down, the decrease of GSH 
concentration coincided (r = 0.9957) with the increase of ascor- 
bate (Fig. lb). The addition of catalase did not affect the rate 
of ascorbate synthesis but prevented the oxidation of GSH in 
microsomal membranes (Table 1), indicating a causal role of 
hydrogen peroxide generated uring ascorbate synthesis. The 
rate of ascorbate synthesis was not dependent on the presence 
or absence of GSH and/or catalase (Table 1). 
Supposing the role of glutathione peroxidase in the ascor- 
bate synthesis-dependent glutathione consumption, we mea- 
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Table 1 
Effect of microsomal ascorbate synthesis on consumption of reduced glutathione 
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Addition Ascorbate GSH 
synthesis consumption 
(nmol/min/mg protein) 
1 mM gulonolactone 
1 mM gulonolactone + catalase 
1 mM gulonolactone + 1 mM GSH 
l mM gulonolactone + 1 mM GSH+catalase 
3.12 + 0.44 
3.20 + 0.21 
3.16+0.33 2.81 +0.16 
3.31 _+0.12 0.36_+0.66* 
Mouse liver microsomes were incubated for 30 min as described in section 2. Ascorbate synthesis was induced by the addition of 1 mM 
gulonolactone. When indicated, 1 mM GSH and/or 1 mg/ml catalase (2800 U/mg; Sigma) was also added. Ascorbic acid and reduced glutathione 
content of the microsomal suspensions were measured after 0 and 30 min of incubation. Mean + S.D. (n =4). Significant difference from the 
corresponding value is indicated: *P < 0.01. 
Table 2 
Effect of glutathione peroxidase inhibitor mercaptosuccinate on gulonolactone dependent microsomal glutathione consumption 
Addition GSH consumption 
(nmol/min/mg protein) 
None 
10 l.tM mercaptosuccinate 
1 mM gulonolactone 1.95 + 0.15 
1 mM gulonolactone + 10 gM mercaptosuccinate 1.38 + 0.02* 
Mouse liver microsomes were incubated for 30 min in the presence of 0.2 mM GSH as described in section 2. Ascorbate synthesis was induced by 
addition of 1 mM gulonolactone. Reduced glutathione content of the microsomal suspensions were measured after 30 min of incubation. 
Mean + S.D. (n = 4). Significant difference from the corresponding value is indicated: *P < 0.01. 
Table 3 
Effect of gulonolactone on ascorbate synthesis and reduced glutathione content of isolated mouse hepatocytes 
Addition Ascorbate synthesis GSH content 
(nmol/min/10 ~ cells) (nmol/106 cells) 
None 0.28 + 0.23 29.7 + 2.7 
10 mM gulonolactone 4.03 + 1.62' 24.6 + 2.2* 
20 mM aminotriazole 0.40 + 0.20 27.2 + 1.8 
10 mM gulonolactone+20 mM aminotriazole 4.26+ 1.77'* 19.4+2.3'** 
Hepatocytes (2x 106 cells/ml) were incubated for 30 min in the presence of gulonolactone and/or the catalase inhibitor aminotriazole. The ascorbic 
acid and reduced glutathione content of the hepatocyte suspension were measured after 0 and 30 min of incubation. Means+ S.D. (n = 8). 
Significant differences: P< 0.01 *vs. control, **vs. aminotriazole, ***vs. gulonolactone. 
sured the microsomal GSH consumption in the presence of 
glutathione peroxidase inhibitor mercaptosuccinate [12]. Mer- 
captosuccinate reduced the glutathione consumption caused 
by gulonolactone (Table 2). 
The effect of enhanced ascorbate synthesis was also inves- 
tigated in isolated mouse hepatocytes. Ascorbate production 
was stimulated by the addition of 10 mM gulonolactone. The 
more than 10-fold increase in ascorbate synthesis was accom- 
panied by a decrease of reduced glutathione content of the 
cells (Table 3). The catalase inhibitor aminotriazole [13] alone 
did not alter the cellular GSH level and ascorbate synthesis 
but deepened the GSH depletion caused by gulonolactone 
addition (Table 3). 
4. Discussion 
In this paper, a new connection between ascorbate and 
GSH metabolism is described. Our data show that the syn- 
thesis of ascorbate leads to consumption of GSH, the other 
main intracellular antioxidant (Fig. 1). We suppose that the 
formation of hydrogen peroxide is underlying the increased 
GSH consumption. First, oxidation of GSH caused by in- 
creased ascorbate synthesis was prevented by the addition of 
catalase in microsomal membranes (Table 1). Second, inhibi- 
tion of glutathione peroxidase by mercaptosuccinate moder- 
ated the gulonolactone-dependent glu athione consumption in 
microsomes (Table 2). Third, the inhibition of catalase by 
aminotriazole deepened the ascorbate synthesis-dependent 
GSH depletion in isolated hepatocytes (Table 3). This inter- 
action may be one of the causes why primates and some other 
species have lost their ascorbate-synthesising ability. This 
event occurred in the ancestors of primates about 70 million 
years ago, owing to mutation(s) in the gulonolactone oxidase 
gene [14]. Despite the well-known benefits [15] of ascorbate, 
the mutation(s) had to be advantageous, as this metabolic 
error did not remain an enzymopathy affecting only a minor- 
ity of the population, but spread widely amongst he species 
(and individuals) of primates and became xclusive [16]. There 
is no explanation for this unexpected outcome. Based on these 
analytical data, the following conceptual evolutionary hypoth- 
esis can be outlined: in the tropical jungle of the Cretaceous 
Period, when exogenous ascorbate was abundant [17,18], the 
loss of gulonolactone oxidase activity could have proved to be 
advantageous. It saved the reduced GSH, the main defence 
system against oxidants, while the access to ascorbate was not 
hindered. Later, the evolutionary gains of these periods al- 
lowed the conservation of the genetic disorder manifested in 
the loss of ascorbate synthesis. 
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Fig. l. Glutathione consumption caused by ascorbate synthesis in li- 
ver microsomal membranes. Microsomes (1 mg/ml protein) were in- 
cubated in the presence of I mM gulonolactone and various concen- 
trations of GSH for 30 min (a) or in the presence of 1 mM 
gulonolactone and GSH for various times (b). Ascorbic acid and re- 
duced glutathione content of the microsomal suspensions were mea- 
sured. Mean + S.D. (n = 6). 
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